Long-term complete remission of metastatic adrenocortical carcinoma

Horm Mol Biol Clin Investig. 2022 Sep 8;44(1):67-71. doi: 10.1515/hmbci-2022-0017. eCollection 2023 Mar 1.

Abstract

Objectives: To report a rare case of a metastatic adrenocortical carcinoma (ACC) that achieve a complete and a long-term remission.

Case presentation: AAC is a rare and aggressive tumor, with a high risk of recurrence and that present metastases in 21% of cases at diagnosis. Treatment of advanced ACC is challenging, mitotane is the only available adrenolytic treatment, with modest and unpredictable responses. Response rates to systemic chemotherapy are not encouraging. We describe the case of a 39-year-old woman with a metastatic ACC, that achieve a complete and long-term remission after chemotherapy, mitotane treatment and surgery of primary tumor and liver metastases.

Conclusions: A complete remission of a metastatic adrenocortical carcinoma is possible in some rare cases after a multimodal treatment.

Keywords: adrenocortical carcinoma; metastatic; remission.

Publication types

  • Case Reports

MeSH terms

  • Adrenal Cortex Neoplasms* / drug therapy
  • Adrenal Cortex Neoplasms* / pathology
  • Adrenocortical Carcinoma* / drug therapy
  • Adrenocortical Carcinoma* / pathology
  • Adult
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Combined Modality Therapy
  • Female
  • Humans
  • Mitotane / therapeutic use

Substances

  • Mitotane
  • Antineoplastic Agents, Hormonal